Dr Reddy’s Laboratories

Dr Reddy’s to acquire Wockhardt’s select generics for Rs 1850 crore

Read more

Pharma Budget 2020

Read more

TechMahindra and Wipro join Dr Reddy’s Laboratories on the Bloomberg Gender-Equality Index

Read more

Dr Reddy’s Laboratories enters nutrition segment with ‘Celevida’ in India

Read more

IPA appoints Satish Reddy as President of IPA for 2019-2021

Read more

Dr Reddy’s Lab gets EIR from US FDA for Vizag units

Read more

Dr Reddy’s launches anti-smoking drug in USA market

Read more

Dr Reddy’s launches generic oral anti-epileptic drug in US

Read more

Dr Reddy’s launches Roche’s Avastin biosimilar in India

Read more

US FDA completes audit of Dr Reddy’s Louisiana-based facility

Read more